188 related articles for article (PubMed ID: 22824225)
21. Using the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) model in clinical research: Application to refine a practice-based research network (PBRN) study.
Elder WG; Munk N
J Am Board Fam Med; 2014; 27(6):846-54. PubMed ID: 25381083
[TBL] [Abstract][Full Text] [Related]
22. Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.
Koppenaal T; Linmans J; Knottnerus JA; Spigt M
J Clin Epidemiol; 2011 Oct; 64(10):1095-101. PubMed ID: 21474282
[TBL] [Abstract][Full Text] [Related]
23. Applying the PRECIS criteria to describe three effectiveness trials of weight loss in obese patients with comorbid conditions.
Glasgow RE; Gaglio B; Bennett G; Jerome GJ; Yeh HC; Sarwer DB; Appel L; Colditz G; Wadden TA; Wells B
Health Serv Res; 2012 Jun; 47(3 Pt 1):1051-67. PubMed ID: 22092292
[TBL] [Abstract][Full Text] [Related]
24. Informing real-world practice with real-world evidence: the value of PRECIS-2.
Neta G; Johnson KE
BMC Med; 2018 May; 16(1):76. PubMed ID: 29783964
[TBL] [Abstract][Full Text] [Related]
25. Integrative Oncology Trials in the Real World: Assessing the Pragmatism of an Ongoing Integrative Oncology Trial of Mindfulness and T'ai Chi/Qigong.
Carlson LE; Oberoi DV; Qureshi M; Subnis U
J Altern Complement Med; 2018; 24(9-10):926-932. PubMed ID: 30247962
[TBL] [Abstract][Full Text] [Related]
26. Pragmatic vs explanatory trials: the pragmascope tool to help measure differences in protocols of mental health randomized controlled trials.
Tosh G; Soares-Weiser K; Adams CE
Dialogues Clin Neurosci; 2011; 13(2):209-15. PubMed ID: 21842618
[TBL] [Abstract][Full Text] [Related]
27. Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.
Forbes G; Loudon K; Clinch M; Taylor SJC; Treweek S; Eldridge S
Trials; 2019 Dec; 20(1):711. PubMed ID: 31829266
[TBL] [Abstract][Full Text] [Related]
28. How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.
Ettori-Ajasse I; Tatin E; Forbes G; Eldridge S; Dibao-Dina C
Trials; 2020 Mar; 21(1):281. PubMed ID: 32188470
[TBL] [Abstract][Full Text] [Related]
29. Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.
Eneling J; Darsaut TE; Patel M; Raymond J
Neurochirurgie; 2023 Jan; 69(1):101403. PubMed ID: 36566693
[TBL] [Abstract][Full Text] [Related]
30. [Progress in research of pragmatic-explanatory continuum indicator summary].
Hu G; Hu Y; Zhan S
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Mar; 37(3):439-42. PubMed ID: 27005554
[TBL] [Abstract][Full Text] [Related]
31. PRECIS-2 for retrospective assessment of RCTs in systematic reviews.
Zwarenstein M; Thorpe K; Treweek S; Loudon K
J Clin Epidemiol; 2020 Oct; 126():202-206. PubMed ID: 32565215
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a short-term residential smoking cessation therapy versus standard outpatient group therapy ('START-Study'): study protocol of a randomized controlled trial.
Dickreuter J; Schmoor C; Bengel J; Jähne A; Leifert JA
Trials; 2020 Jun; 21(1):562. PubMed ID: 32576275
[TBL] [Abstract][Full Text] [Related]
33. Articles provided insufficient information to conduct an appropriate retrospective assessment of the pragmatic/explanatory features of medicine trials with the PRECIS-2 tool.
Dal-Ré R
Eur J Clin Pharmacol; 2020 Aug; 76(8):1093-1102. PubMed ID: 32447436
[TBL] [Abstract][Full Text] [Related]
34. Trends in the Explanatory or Pragmatic Nature of Cardiovascular Clinical Trials Over 2 Decades.
Sepehrvand N; Alemayehu W; Das D; Gupta AK; Gouda P; Ghimire A; Du AX; Hatami S; Babadagli HE; Verma S; Kashour Z; Ezekowitz JA
JAMA Cardiol; 2019 Nov; 4(11):1122-1128. PubMed ID: 31473763
[TBL] [Abstract][Full Text] [Related]
35. The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team.
Riddle DL; Johnson RE; Jensen MP; Keefe FJ; Kroenke K; Bair MJ; Ang DC
J Clin Epidemiol; 2010 Nov; 63(11):1271-5. PubMed ID: 20670911
[TBL] [Abstract][Full Text] [Related]
36. CHARTing a Path to Pragmatic Tobacco Treatment Research.
Cruvinel E; Richter KP; Stoney C; Duffy S; Fellows J; Harrington KF; Rigotti NA; Sherman S; Tindle HA; Shireman TI; Shelley D; Waiwaiole L; Cummins S
Am J Prev Med; 2016 Oct; 51(4):630-6. PubMed ID: 27647063
[TBL] [Abstract][Full Text] [Related]
37. PRECIS-2 analysis of pragmatic acupuncture trials: a systematic review.
Lim J; Lee H; Kim YS
BMC Complement Med Ther; 2024 May; 24(1):181. PubMed ID: 38702632
[TBL] [Abstract][Full Text] [Related]
38. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.
Saesen R; Depreytere K; Krupianskaya K; Langeweg J; Verheecke J; Lacombe D; Huys I
BMC Med Res Methodol; 2023 Jun; 23(1):148. PubMed ID: 37355603
[TBL] [Abstract][Full Text] [Related]
40. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
